Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
People receiving dialysis experience profound disruptions to daily life and social roles. Loneliness and social isolation are common and are associated with worse quality of life, higher morbidity and mortality. Despite patient priorities identifying life and social participation as a critical outcome, there is a paucity of rigorous trials testing interventions to improve social connections in this population. CONNECTeD is a co-designed pilot randomised controlled trial that evaluates whether a social prescribing model delivered by link workers with lived experience of kidney failure improves loneliness and other patient-centred and health service outcomes for adults receiving dialysis.
CONNECTeD is a multi-centre, parallel-group randomised controlled pilot trial across four dialysis units in Sydney, Australia. Adults receiving in-centre haemodialysis, home haemodialysis or peritoneal dialysis will be randomised (N=144; 72 intervention, 72 control). For in-centre patients pragmatic day-of-week cluster randomisation will be used to minimise contamination. Home-based patients will be individually randomised with stratification by modality. The intervention comprises an initial link-worker consultation, personalised referral to patient-prioritised community activities (peer support, education, exercise, arts, social groups, psychosocial support), and scheduled follow-up (weekly for month 1, fortnightly for months 2–3). Control participants receive usual care. The primary outcome is change in loneliness at 3 months measured by the UCLA Loneliness Scale (Version 3). Secondary outcomes include social isolation (LSNS-6), life participation (PROMIS Ability to Participate), fatigue (FACIT-F), depression (PHQ-9), EQ-5D-5L utility, technique survival, hospitalisations, mortality, adherence, and intervention costs. We will conduct intention-to-treat analyses, mixed models for longitudinal measures, and a within-trial cost-effectiveness and cost-utility analysis (QALYs). A process evaluation will assess fidelity, reach, acceptability and mechanisms.
As a pilot RCT powered to detect clinically meaningful change in loneliness, CONNECTeD will produce estimates of effect size, variance, feasibility (recruitment, retention, adherence), implementation barriers/facilitators, and economic impact required to plan a definitive effectiveness and implementation trial. We hypothesise the intervention will reduce loneliness at 3 months, increase life participation and utility-based quality of life, and demonstrate favorable cost-effectiveness from a health service perspective.
CONNECTeD is the first randomised trial of social prescribing in people receiving dialysis. By combining consumer co-design, link workers with lived experience, robust outcome measurement (including SONG core outcomes), economic evaluation and process evaluation, CONNECTeD will generate critical evidence on feasibility, preliminary efficacy and value of social prescribing to inform scalable models of care that address patient-prioritised outcomes in kidney failure.
